Here, we have demonstrated the therapeutic efficacy of anti-SEMA4D antibody treatment in alleviating phenotypic symptoms and functional deficits in a transgenic mouse model of Rett syndrome. This evidence concerns the gene SEMA4D and Rett syndrome.